Pineapple Studio Limit Buying Bonanza: 5 Blue-Chips I Just Bought And Two I Sold Here's a summary of the limits that I filled the morning of Monday, June 10, since my readers seem most interested in what I'm doing with my own hard-earned money. British American Tobacco (BTI) Trade Summary Shares purchased: 400 (then 200 more in a 2nd limit) Price: $31.25 (9.5% yield) ($30.64) (9.7% yield) Shares I Now Own: 6,066.4674 Cost Basis: $30.08 (9.9% yield) British American was a "fat finger" slip when I was enter ...

Core Insights - The Catalytic Transition Fund (CTF) has been launched to direct capital into clean energy and transition assets in emerging markets, with a commitment of $1 billion from UAE-backed ALTÉRRA aimed at catalyzing up to $5 billion in total capital [1][2][3] Group 1: Fund Overview - CTF is designed to address the urgent need for climate transition investments in emerging economies, which currently receive less than 15% of global clean energy investment despite being responsible for nearly one-third of global emissions [2][4] - The fund will focus on deploying capital in target emerging markets, including South and Central America, South and Southeast Asia, the Middle East, and Eastern Europe, with at least 10% of the total capital contributed by Brookfield [4][5] Group 2: Strategic Goals - ALTÉRRA aims to deploy $30 billion in climate investments by 2030, with a goal to catalyze $250 billion globally through innovative partnerships [2][9] - The CTF represents a unique private capital approach to attract investment for clean energy and transition assets, improving risk-adjusted returns for investors [3][5] Group 3: Market Context - The need for clean energy investment in emerging markets is projected to increase six times to reach $1.6 trillion per year by the early 2030s to align with the Paris Agreement [2] - Brookfield is recognized as a leading transition investor, having raised a record $15 billion in its first fund of the Brookfield Global Transition Fund series in 2022 [4][5]

ANN ARBOR, Mich., June 11, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today that production of its BAM-1 spider silk hybrid strain continues to set records for silkworm size, growth, and robustness. The Company announced in early June that it had accelerated its production schedule for its new BAM-1 hybrids based on the results of its spring production trials. The rearing of this first batch of production hybrids is now well underway. ...

BROOKFIELD, NEWS, June 07, 2024 (GLOBE NEWSWIRE) -- Brookfield Asset Management Ltd. (NYSE:BAM, TSX:BAM) today announced that all six nominees proposed for election to the board of directors by holders of Class A Limited Voting Shares ("Class A Shares") and all six nominees proposed for election to the board of directors by the holder of Class B Limited Voting Shares ("Class B Shares") were elected at the company's annual meeting of shareholders held on June 7, 2024 in a virtual meeting format. Detailed res ...

24/7 Market News Publishes Report on how Kraig Biocraft's BAM-1 Spider Silk Hybrid Production Affects Spider Silk MarketJune 05, 2024 9:01 AM EDT | Source: 24/7 Market NewsDenver, Colorado--(Newsfile Corp. - June 5, 2024) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, today publishes a news report on Kraig Biocraft Laboratories (OTCQB: KBLB) launching the production phase for its BAM-1 recombinant spider silk hybrid ...

Core Insights - Kraig Biocraft Laboratories, Inc. has commenced production of its BAM1 recombinant spider silk hybrids, accelerating its 2024 production schedule due to successful production trials [1][3] - The current production cycle represents a significant increase, with over a 10X rise in production compared to spring trials, marking the largest single batch in the company's history [1][2] - The BAM-1 hybrids have shown excellent hatching yield and robust growth, with no signs of disease or weakness observed in the colony [2] Company Developments - The BAM-1 hybrids were developed by integrating the company's Dragon Silk™ technology into two commercial silkworm strains, resulting in larger cocoons and improved silk yield [2] - The successful launch is attributed to over a year of focused development, positioning the company to achieve its first production milestone of a metric ton of spider silk [3] - The company plans to provide further updates on production growth and market developments in the coming weeks [3] Industry Context - Kraig Labs is recognized as a leading developer of genetically engineered spider silk-based fiber technologies, with significant implications for the global textile industry [4]

Ann Arbor, Michigan--(Newsfile Corp. - May 28, 2024) - Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs") announces an update on the commercialization of its BAM-1 recombinant spider silk production hybrids.First made public in February of 2024, as part of the Company's now successfully concluded spring production trails, the BAM-1 hybrid is the latest development in recombinant spider silk production technology.Kraig Labs' BAM-1 production platform has proven to be the most ro ...

tadamichiJust a couple of decades ago, it was very difficult for investors to access alternative investments like private equity, venture capital, commercial real estate, infrastructure, and so on. These investments were reserved to the wealthiest and best-connected investors, and the rest of us were limited to regular stocks and bonds for the most part. But times have changed, and today it is easier than ever before to invest in alternative investments. Many of them are publicly listed. Some are also o ...

Financial Data and Key Metrics - Fee-related earnings (FRE) for Q1 2024 were $552 million, with $2.2 billion over the last 12 months [26] - Distributable earnings (DE) for Q1 2024 were $547 million, with $2.2 billion over the last 12 months [26] - Fee-bearing capital grew by 6% year-over-year to nearly $460 billion, driven by strong inflows and capital deployment [28][29] - The company raised $20 billion of capital in Q1 2024, including $10 billion previously announced in February [28] - The company has over $100 billion of dry powder available for deployment, with $11 billion deployed in Q1 2024, primarily in credit products [30] Business Line Data and Key Metrics - Infrastructure business raised over $3 billion, including $2 billion for the Supercore Infrastructure strategy [34] - Renewable Power and Transition business held a first close for the second vintage of the Global Transition Fund at $10 billion [34] - Private equity raised $1.5 billion in Q1 2024, with several complementary strategies launched [35] - Real estate held a first close for the fifth vintage of the Opportunistic Real Estate Fund at over $8 billion [35] - Credit business raised nearly $6 billion within Oaktree funds, including $1 billion in sponsor credit and $1 billion in the 12th vintage of the Opportunistic Credit Fund [36] Market Data and Key Metrics - The company sold a 49% interest in ICD Brookfield Place, a premier office property in Dubai, for approximately $1.5 billion, marking one of the largest real estate transactions globally since the pandemic [10] - Over the past year, the company sold or is under contract to sell approximately $35 billion of assets across all businesses, generating strong returns on capital [10] - The company refinanced over $18 billion of borrowings, resulting in a decrease in the overall cost of debt [11] Company Strategy and Industry Competition - The company is focusing on long-term growth through flagship funds, complementary strategies, and the Brookfield Reinsurance platform [14] - The company has a leadership position in infrastructure, renewable power, transition, and credit, which are in high demand due to global megatrends like decarbonization, deglobalization, and digitalization [16] - The company is expanding its wealth solutions business, with Brookfield Reinsurance managing nearly $90 billion of insurance fee-bearing capital, including $50 billion from the AEL acquisition [18][19] - The company is consolidating its credit businesses under a newly formed credit group, which manages nearly $300 billion of assets under management [38] Management Commentary on Operating Environment and Future Outlook - The company expects excellent growth in overall results in 2024, driven by strong fundraising, capital markets execution, and strategic transactions [8] - The market environment is improving, with liquidity returning to capital markets and risk appetite increasing among investors [8] - The company expects fundraising to continue to build throughout the year, with three flagship funds expecting final closes in 2024 [14] - The company is confident in reaching its targets of doubling distributable earnings and reaching over $1 trillion of fee-bearing capital over the next four years [25] Other Important Information - The company declared a dividend of $0.38 per share for Q1 2024, payable on June 28th [31] - Bahir Manios, the CFO, will be stepping down at the end of May, with Hadley Peer Marshall taking over as the new CFO [13][32] Q&A Session Summary Question: Fund performance track records and market volatility - The company views the slight decline in fund performance as temporary, with expectations of a rebound as market conditions improve [44] Question: Castlelake deal structure - The company invested $500 million in Castlelake, with $350 million for a 51% stake in FRE and $150 million for carry and GP stakes [47] Question: Fundraising pace and flagship fund expectations - The company expects fundraising to be more balanced across quarters in 2024, with strong momentum in credit and real estate flagship funds [52][53] Question: Insurance business and AEL asset rotation - The company expects to deploy 1/3 of AEL capital into private funds, 1/3 into investment-grade credit, and 1/3 into liquid credit over the next 2-3 years [55][56] Question: Credit business competitive environment - The company sees strong opportunities in credit due to market disruptions, scarcity of capital, and its ability to provide certainty of capital and quick execution [59][60] Question: FRE margin and expense growth - The company maintains its guidance for low double-digit expense growth and expects FRE margins to improve as fundraising becomes more balanced and capital deployment increases [71][72] Question: Castlelake transaction multiple - The $350 million investment for 51% of Castlelake's FRE implies a forward-looking multiple of 9x, with $40 million expected over the next 12 months [75] Question: Oaktree incremental interest acquisition - The company invested $275 million for an additional 5% interest in Oaktree, with a multiple of 13.5x based on a formulaic calculation [77] Question: Impact of U.S. Department of Labor rules on AEL business - The company sees demographic trends supporting growth in the insurance business, with minimal disruption expected from new regulations [81][82]

EXHIBIT 99.1 Brookfield Asset Management Announces Strong First Quarter Results Insurance Flows and Castlelake Add $75 Billion of AUM Since Quarter End $106 Billion of Dry Powder Available to Invest BROOKFIELD, NEWS, May 08, 2024 (GLOBE NEWSWIRE) -- Brookfield Asset Management Ltd. (NYSE: BAM, TSX: BAM) today announced financial results for the quarter ended March 31, 2024. Connor Teskey, President of Brookfield Asset Management stated, "We are off to a strong start in 2024 and are seeing accelerating momen ...